ZUG, Switzerland--(BUSINESS WIRE)--Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its financial results for the full year 2024, delivering strong results for ...

The repurchased shares will be held in treasury and financed by existing liquidity at hand Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it intends to ...

ZURICH, April 23 (Reuters) - Swiss skincare firm Galderma on Thursday said first-quarter sales jumped 25.5% in ...

If you are wondering whether Galderma Group is still attractive after its big run, or if the easy money has already been made, you are not alone. That is exactly what this valuation deep dive will ...

The United States (U.S.) Food and Drug Administration (FDA) has approved Restylane Contour* for the correction of temple hollowing, expanding its use beyond cheek augmentation and midface contour ...

Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its sales performance for the first quarter of 2026. Strong start to the ...

Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that Thomas Dittrich, Chief Financial Officer, will be leaving the company to pursue another senior executive ...

Galderma will present two late-breaking presentations on clinical trials evaluating the long-term efficacy of the investigational monoclonal antibody nemolizumab in prurigo nodularis and its ...

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it has agreed to repurchase 1.6 million shares at a price of CHF 143.75 per share for a total consideration of CHF ...

Add Yahoo as a preferred source to see more of our stories on Google. PARIS — Swiss skin care company Galderma’s shares soared Friday, the first day of trading on the SIX Swiss Exchange in Zurich. The ...

Dermatology specialist Galderma has claimed a second FDA approval for IL-31 inhibitor Nemluvio, adding atopic dermatitis to its label. Nemluvio (nemolizumab) – which was approved by the FDA in the ...

ZURICH, April 23 (Reuters) - Swiss skincare company Galderma said on Thursday that first-quarter sales jumped 25.5% in ...